Bullenkamp, J., Raulf, N., Ayaz, B., Walczak, H., Kulms, D., Odell, E., . . . Tavassoli, M. (2014). Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism. Cell Death Dis.
Citación estilo ChicagoBullenkamp, J., N. Raulf, B. Ayaz, H. Walczak, D. Kulms, E. Odell, S. Thavaraj, y M. Tavassoli. "Bortezomib Sensitises TRAIL-resistant HPV-positive Head and Neck Cancer Cells to TRAIL Through a Caspase-dependent, E6-independent Mechanism." Cell Death Dis 2014.
Cita MLABullenkamp, J., et al. "Bortezomib Sensitises TRAIL-resistant HPV-positive Head and Neck Cancer Cells to TRAIL Through a Caspase-dependent, E6-independent Mechanism." Cell Death Dis 2014.
Precaución: Estas citas no son 100% exactas.